| Jump to: | Authorized Access | | | Attribution | | | Authorized Requests |
- Study Description
-
Important Links and Information
-
Request access via Authorized Access
- Instructions for requestors
- Data Use Certification (DUC) Agreement
- Talking Glossary of Genetic Terms
Lung adenocarcinoma in people who have never smoked (NS-LUAD) has a high mortality rate. Knowing NS-LUAD phenotypic plasticity and cell composition can provide guidance for prognosis and treatment. This study comprises large RNA-seq data set from 684 tumor samples from NS-LUAD, including 610 from the Sherlock-Lung Study and 74 downloaded from the public TCGA-LUAD data set. We investigate cell dynamics through the transcriptomic data.
- Study Weblinks:
- Study Design:
- Case Set
- Study Type:
- Case Set
- RNA Sequencing
- Tumor
- Total number of consented subjects: 610
- Subject Sample Telemetry Report (SSTR)
-
Request access via Authorized Access
- Authorized Access
- Publicly Available Data
- Selected Publications
- Diseases/Traits Related to Study (MeSH terms)
-
- Primary Phenotype: Adenocarcinoma of Lung
- Authorized Data Access Requests
- Study Attribution
-
-
Principal Investigator
- Maria Teresa Landi. Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
-
Co-Investigator
- Wei Zhao. Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
-
Funding Sources
- Intramural Research Program of NCI, NIH. Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- The Anne Wojcicki Foundation. Los Altos, CA, USA.
-
Principal Investigator